Aghadi M, Elgendy R, Abdelalim EM. Loss of FOXA2 induces ER stress and hepatic steatosis and alters developmental gene expression in human iPSC-derived hepatocytes. Cell Death Dis. 2022;13(8):713.
Article CAS PubMed PubMed Central Google Scholar
Alizadeh E, Akbarzadeh A, Eslaminejad MB, Barzegar A, Hashemzadeh S, Nejati-Koshki K, Zarghami N. Up regulation of liver-enriched transcription factors HNF4a and HNF6 and liver-specific microRNA (miR-122) by inhibition of let-7b in mesenchymal stem cells. Chem Biol Drug Des. 2015;85(3):268–79.
Article CAS PubMed Google Scholar
Begum S. Hepatic nuclear factor 1 alpha (HNF-1α) in human physiology and Molecular Medicine. Curr Mol Pharmacol. 2020;13(1):50–6.
Article CAS PubMed Google Scholar
Beinsteiner B, Billas IML, Moras D. Structural insights into the HNF4 biology. Front Endocrinol. 2023;14:1197063.
Blaas L, Kornfeld JW, Schramek D, Musteanu M, Zollner G, Gumhold J, van Zijl F, Schneller D, Esterbauer H, Egger G, et al. Disruption of the growth hormone–signal transducer and activator of transcription 5–insulinlike growth factor 1 axis severely aggravates liver fibrosis in a mouse model of cholestasis. Hepatology (Baltimore MD). 2010;51(4):1319–26.
Article CAS PubMed Google Scholar
Bochkis IM, Rubins NE, White P, Furth EE, Friedman JR, Kaestner KH. Hepatocyte-specific ablation of Foxa2 alters bile acid homeostasis and results in endoplasmic reticulum stress. Nat Med. 2008;14(8):828–36.
Article CAS PubMed PubMed Central Google Scholar
Briançon N, Bailly A, Clotman F, Jacquemin P, Lemaigre FP, Weiss MC. Expression of the alpha7 isoform of hepatocyte nuclear factor (HNF) 4 is activated by HNF6/OC-2 and HNF1 and repressed by HNF4alpha1 in the liver. J Biol Chem. 2004;279(32):33398–408.
Brie B, Ornstein A, Ramirez MC, Lacau-Mengido I, Becu-Villalobos D. Epigenetic modifications in the GH-dependent Prlr, Hnf6, Cyp7b1, Adh1 and Cyp2a4 genes. J Mol Endocrinol. 2020;64(3):165–79.
Article CAS PubMed Google Scholar
Campagno RV, Nosetto EC, Brandoni A, Torres AM. Hepatic and renal expression of Oatp1 in obstructive uropathy. First detection of Oatp1 in urine, a potential biomarker. Clin Exp Pharmacol Physiol. 2021;48(7):987–95.
Article CAS PubMed Google Scholar
Chavan R, Preitner N, Okabe T, Strittmatter LM, Xu C, Ripperger JA, Pitteloud N, Albrecht U. REV-ERBα regulates Fgf21 expression in the liver via hepatic nuclear factor 6. Biology open. 2017;6(1):1–7.
Delesque-Touchard N, Park SH, Waxman DJ. Synergistic action of hepatocyte nuclear factors 3 and 6 on CYP2C12 gene expression and suppression by growth hormone-activated STAT5b. Proposed model for female specific expression of CYP2C12 in adult rat liver. J Biol Chem. 2000;275(44):34173–82.
Article CAS PubMed Google Scholar
Delgado ME, Cárdenas BI, Farran N, Fernandez M. Metabolic reprogramming of liver fibrosis. Cells 2021;10(12).
Geng L, Lam KSL, Xu A. The therapeutic potential of FGF21 in metabolic diseases: from bench to clinic. Nat Reviews Endocrinol. 2020;16(11):654–67.
Glaser S, Wang M, Ueno Y, Venter J, Wang K, Chen H, Alpini G, Holterman A. Differential transcriptional characteristics of small and large biliary epithelial cells derived from small and large bile ducts. Am J Physiol Gastrointest Liver Physiol. 2010;299(3):G769–777.
Article CAS PubMed PubMed Central Google Scholar
Hao R, He J, Liu X, Gao G, Liu D, Cui L, Yu G, Yu W, Chen Y, Guo D. Inhibition of hepatitis B virus gene expression and replication by hepatocyte nuclear factor 6. J Virol. 2015;89(8):4345–55.
Article CAS PubMed PubMed Central Google Scholar
Holterman AX, Tan Y, Kim W, Yoo KW, Costa RH. Diminished hepatic expression of the HNF-6 transcription factor during bile duct obstruction. Hepatology (Baltimore MD). 2002;35(6):1392–9.
Article CAS PubMed Google Scholar
Iannacone M, Guidotti LG. Immunobiology and pathogenesis of hepatitis B virus infection. Nat Rev Immunol. 2022;22(1):19–32.
Article CAS PubMed Google Scholar
Jacquemin P, Durviaux SM, Jensen J, Godfraind C, Gradwohl G, Guillemot F, Madsen OD, Carmeliet P, Dewerchin M, Collen D, et al. Transcription factor hepatocyte nuclear factor 6 regulates pancreatic endocrine cell differentiation and controls expression of the proendocrine gene ngn3. Mol Cell Biol. 2000;20(12):4445–54.
Article CAS PubMed PubMed Central Google Scholar
Jiang K, Jiao Y, Liu Y, Fu D, Geng H, Chen L, Chen H, Shen X, Sun L, Ding K. HNF6 promotes tumor growth in colorectal cancer and enhances liver metastasis in mouse model. J Cell Physiol. 2019;234(4):3675–84.
Article CAS PubMed Google Scholar
Kawashima K, Andreata F, Beccaria CG, Iannacone M. Priming and maintenance of adaptive immunity in the liver. Annu Rev Immunol. 2024;42(1):375–99.
Article CAS PubMed Google Scholar
Kumar A, Sundaram K, Teng Y, Mu J, Sriwastva MK, Zhang L, Hood JL, Yan J, Zhang X, Park JW, et al. Ginger nanoparticles mediated induction of Foxa2 prevents high-fat diet-induced insulin resistance. Theranostics. 2022;12(3):1388–403.
Article CAS PubMed PubMed Central Google Scholar
Lange CM, Weismüller TJ, Strassburg CP. [Liver transplantation in viral and autoimmune liver diseases]. Innere Medizin (Heidelberg Germany). 2024;65(4):357–64.
Lau HH, Ng NHJ, Loo LSW, Jasmen JB, Teo AKK. The molecular functions of hepatocyte nuclear factors - in and beyond the liver. J Hepatol. 2018;68(5):1033–48.
Article CAS PubMed Google Scholar
Lee YS, Kim DK, Kim YD, Park KC, Shong M, Seong HA, Ha HJ, Choi HS. Orphan nuclear receptor SHP interacts with and represses hepatocyte nuclear factor-6 (HNF-6) transactivation. Biochem J. 2008;413(3):559–69.
Article CAS PubMed Google Scholar
Lehner F, Kulik U, Klempnauer J, Borlak J. The hepatocyte nuclear factor 6 (HNF6) and FOXA2 are key regulators in colorectal liver metastases. FASEB Journal: Official Publication Federation Am Soc Experimental Biology. 2007;21(7):1445–62.
Lehner F, Kulik U, Klempnauer J, Borlak J. Inhibition of the liver enriched protein FOXA2 recovers HNF6 activity in human colon carcinoma and liver hepatoma cells. PLoS ONE. 2010;5(10):e13344.
Article PubMed PubMed Central Google Scholar
Lemaigre FP, Durviaux SM, Rousseau GG. Liver-specific factor binding to the liver promoter of a 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase gene. J Biol Chem. 1993;268(26):19896–905.
Article CAS PubMed Google Scholar
Liu X, Hou S, Xiang R, Hu C, Chen Z, Li N, Yan H, Yu X, Li X, Chi Y, et al. Imipramine activates FAM3A-FOXA2-CPT2 pathway to ameliorate hepatic steatosis. Metab Clin Exp. 2022;136:155292.
Article CAS PubMed Google Scholar
Mu YP, Xi XH, Chen XR. [Mechanism of hepatocyte regeneration inhibition in rats with liver fibrosis induced by lipogenic methionine-choline- deficient diet]. Zhonghua Yi Xue Za Zhi. 2009;89(48):3430–6.
Park JH, Iwamoto M, Yun JH, Uchikubo-Kamo T, Son D, Jin Z, Yoshida H, Ohki M, Ishimoto N, Mizutani K, et al. Structural insights into the HBV receptor and bile acid transporter NTCP. Nature. 2022;606(7916):1027–31.
Article CAS PubMed PubMed Central Google Scholar
Peng YC, Lv TH, Du ZK, Cun XN, Yang KM. Liver macrophages stimulate the expression of hepatocyte nuclear Factor-6 and promote hepatocyte proliferation at the early stage of liver regeneration. Bull Exp Biol Med. 2020;170(1):40–5.
Comments (0)